Damora Therapeutics (DMRA) Profit After Tax (2019 - 2026)
Damora Therapeutics (DMRA) posted Profit After Tax of -$27.8 million for Q1 2026, down 405.91% on a QoQ basis from $9.1 million in Q4 2025, and down 1092.4% year-over-year from $2.8 million in Q1 2025.
Damora Therapeutics (DMRA) Profit After Tax (2019 - 2026) Analysis & Trends
Damora Therapeutics' Profit After Tax history runs 8 years deep, the most recent figure standing at -$27.8 million for Q1 2026.
- Quarterly Profit After Tax fell 1092.4% year-over-year to -$27.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.2 million (down 1.25% YoY) and the FY2025 annual result came in at $705000.0, up 103.29% from the prior year.
- Profit After Tax was -$27.8 million for Q1 2026 at Damora Therapeutics, down from $9.1 million in the prior quarter.
- Across five years, Profit After Tax topped out at $49.2 million in Q4 2022 and bottomed at -$27.8 million in Q1 2026.
- A 5-year average of -$3.6 million and a median of -$5.5 million in 2024 frame the typical range for Profit After Tax.
- Peak annual rise in Profit After Tax reached 441.85% in 2022, while the deepest fall reached 9694.89% in 2022.
- Damora Therapeutics' Profit After Tax stood at $49.2 million in 2022, then plunged by 111.88% to -$5.9 million in 2023, then declined by 15.21% to -$6.7 million in 2024, then jumped by 234.73% to $9.1 million in 2025, then tumbled by 405.91% to -$27.8 million in 2026.
- Business Quant data shows DMRA's Profit After Tax at -$27.8 million in Q1 2026, $9.1 million in Q4 2025, and $14000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - | -27.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.78 Mn |
| Dec 31, 2025 | 9.08 Mn |
| Sep 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 509,000.00 |
| Mar 31, 2025 | -2.33 Mn |
| Dec 31, 2024 | -6.74 Mn |
| Sep 30, 2024 | -3.42 Mn |
| Jun 30, 2024 | -5.47 Mn |
| Mar 31, 2024 | -5.53 Mn |
| Dec 31, 2023 | -5.85 Mn |
| Sep 30, 2023 | -7.95 Mn |
| Jun 30, 2023 | -10.75 Mn |
| Mar 31, 2023 | -12.99 Mn |
| Dec 31, 2022 | 49.24 Mn |
| Sep 30, 2022 | -14.16 Mn |
| Jun 30, 2022 | -16.89 Mn |
| Mar 31, 2022 | -375,000.00 |
| Dec 31, 2021 | -14.40 Mn |
| Sep 30, 2021 | -13.03 Mn |
| Jun 30, 2021 | 176,000.00 |